MODULATION OF THE THETA-GAMMA NEURAL CODE WITH CONTROLLED LIGHT THERAPEUTICS
20230126680 · 2023-04-27
Inventors
Cpc classification
A61N2005/0626
HUMAN NECESSITIES
A61B5/374
HUMAN NECESSITIES
A61B5/0077
HUMAN NECESSITIES
A61N5/10
HUMAN NECESSITIES
A61B5/4836
HUMAN NECESSITIES
International classification
A61B5/00
HUMAN NECESSITIES
A61B5/16
HUMAN NECESSITIES
A61B5/374
HUMAN NECESSITIES
Abstract
Gamma brain stimulation (around 40 Hz) is performed using light pulses. To perform theta brain stimulation (around 7 Hz) without perceptible flicker, the light source is also strobed at 47 Hz (also within the gamma range). The brain perceives the 40 Hz and a subtraction frequency of 7 Hz (in the theta range). The combined gamma and theta wave stimulation of the brain may be used for preventing or treating brain disease or sleeping disorders. The particular stimulation frequencies and their phases create neuronal gamma-theta coupling in the brain that has been shown to have positive effects on memory, Alzheimer's disease, motor skills, and other functions. Other gamma and theta frequencies, creating gamma-theta coupling in the brain, are also beneficial. The phase of the light pulses is also dynamically controlled using feedback to maximize theta-gamma coupling in the brain.
Claims
1. A brain stimulation system for a person comprising: one or more power supplies controlled to energize a light source at multiple frequencies; and the light source coupled to the one or more power supplies for being controlled to generate light at a first brain stimulation rate within a gamma wave range of 20-140 Hz and at a second brain stimulation rate of the first brain stimulation rate plus a theta wave range of 4-10 Hz.
2. The system of claim 1 wherein the one or more power supplies controls the light source to generate the light at a first frequency within the gamma wave range of 20-140 Hz and also controls the light source to simultaneously generate the light at a second frequency that is greater than the first frequency by 4-10 Hz.
3. The system of claim 1 wherein the one or more power supplies controls the light source to alternate between generating the light at a first frequency within the gamma wave range of 20-140 Hz and generating the light at a second frequency that is greater than the first frequency by 4-10 Hz.
4. The system of claim 1 wherein the one or more power supplies controls the light source to generate the light at a first frequency within the gamma wave range of 20-140 Hz while being modulated by a second frequency of 4-10 Hz.
5. The system of claim 1 wherein a first power supply controls a first set of light emitting diodes (LEDs) within the light source to flicker at the first brain stimulation rate, and wherein a second power supply controls a second set of LEDs within the light source to flicker a the second brain stimulation rate.
6. The system of claim 1 wherein the one or more power supplies controls light emitting diodes (LEDs) within the light source to flicker at the first brain stimulation rate and also controls the LEDs to flicker at the second brain stimulation rate.
7. The system of claim 1 further comprising: one or more EEG sensors for detecting brain waves; and a processing system coupled to detect first signals corresponding to the brain waves and coupled to control a phase of the generated light from the light source to increase theta-gamma wave coupling in the person's brain.
8. The system of claim 7 wherein the one or more EEG sensors detects electrical emissions from at least one of the MEC and hippocampus areas of the person's brain.
9. The system of claim 1 further comprising: a processing system; an eye-tracking device that detects said person's eye and provides first data to the processing system, wherein the processing system is configured to use the first data to adjust aspects of a brain stimulation session.
10. The stimulation system of claim 9 wherein the first data corresponds to the person's gaze angle with respect to the light source.
11. The stimulation system of claim 9 wherein the first data corresponds to the person's distance to the light source.
12. The stimulation system of claim 9 wherein the first data corresponds to the person's pupil size.
13. The stimulation system of claim 9 wherein the processing system is configured to adjust a duration of the brain stimulation session based on the first data.
14. The stimulation system of claim 11 wherein the processing system is configured to extend the duration of the brain stimulation session based on the first data.
15. The stimulation system of claim 9 further comprising a display of a duration of the brain stimulation session as the session is adjusted.
16. The stimulation system of claim 9 wherein the eye-tracking device comprises a camera.
17. The stimulation system of claim 9 wherein the processing system is configured to receive a target dosage of the brain stimulation, corresponding to a brain stimulation session time, and the first data is used to adjust a duration of the session time.
18. The stimulation system of claim 9 further comprising a memory, wherein second data corresponding to the brain stimulation session is stored in the memory for later retrieval.
19. The stimulation system of claim 9 wherein the brain stimulation is used for treating brain disorders.
20. The stimulation system of claim 9 further comprising a communications system, wherein the communications system transmits second data relating to the session for use in determining an efficacy of the brain stimulation.
21. The simulation system of claim 1 wherein the light source generates light that alternates between at least two different colors to generate heterochromatic flicker.
22. A brain stimulation method for a person comprising: strobing a light source at a first brain stimulation rate in a gamma wave range between about 20-140 Hz; and strobing the light source at a second brain stimulation rate of the first brain stimulation rate plus a theta wave range of 4-10 Hz.
23. The method of claim 22 wherein the light source is simultaneously being strobed at the first brain stimulation rate and the second brain stimulation rate.
24. The method of claim 22 wherein the light source is alternately strobed at the first brain stimulation rate and at the second brain stimulation rate.
25. The method of claim 22 wherein the light source comprises a plurality of light emitting diodes (LEDs), where one set of the LEDs is strobed at the first brain stimulation rate, and a second set of LEDs is strobed at the second brain stimulation rate.
26. The method of claim 22 further comprising: detecting brain waves using one or more EEG sensors; detecting first signals corresponding to the brain waves; and controlling a phase of generated light from the light source to increase theta-gamma wave coupling in the person's brain.
27. The method of claim 22 wherein the light source generates light that alternates between at least two different colors to generate heterochromatic flicker.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049] Elements labelled with the same numerals in the various drawings may be the same or equivalent.
DETAILED DESCRIPTION
[0050]
[0051] A gamma/theta brain stimulation light system 12 is positioned about 50-100 cm from the person 10. The system may be supported by a table or desk. In another embodiment, the system forms goggles that are worn by the person 10.
[0052] In one embodiment, a pulsing light source 14 uses blue light LEDs, white light LEDs, or a variety of different wavelength monochromatic LEDs.
[0053] One set of LEDs is energized at 40 Hz (or other gamma frequency) and another set of LEDs is simultaneously energized at 47 Hz (or other theta frequency). The combined light perceived by the person's brain will be 40 Hz and a beat frequency (subtraction frequency) of 7 Hz. The flickering is near to imperceptible at 40 Hz.
[0054] The 40 Hz and 47 Hz frequencies are preferred but not required. A gamma brain stimulation rate range between 20 Hz-140 Hz may be effective, and a theta brain stimulation rate range between 4 Hz-10 Hz may be effective. Therefore, the two light flickering frequencies would differ by 4-10 Hz and be in the range of 20-150 Hz. This would result in the brain being stimulated at the gamma frequency and the beat theta frequency.
[0055] The LEDs are optionally arranged to form a circular light source 14 with a camera lens 16 in the middle. In another embodiment, the light source 14 may be more of a point source, and the camera lens 16 may be next to it. In that case, the gaze angle is adjusted for the offset of the lens and the light source. The light source 14 may instead be a flat two-dimensional array of LEDs, such as 20 cm×20 cm diffused Lambertian source.
[0056] In another embodiment, the LEDs are energized to output light whose amplitude is sinusoidal. In such a case, the energizing currents to different sets of LEDs are 40 Hz and 47 Hz, so there is no perceived flicker.
[0057] In another embodiment, the LEDs are energized for a time (a few seconds) at 40 Hz, followed by being energized for a few seconds at 47 Hz, where the alternation is less than 6 seconds. The brain will perceive the frequencies as being modulated.
[0058] In another embodiment, instead of the light alternating between white and darkness, the light can alternate between different colors at the stimulation frequencies, such as between green and red and between blue and yellow. For example, one light source can alternate at 47 Hz between the colors XX and the color YY, and the other light source can alternate at 40 Hz between the colors ZZ and KK. This is referred to as heterochromatic flicker. The heterochromatic flicker can be constructed by multiple combinations of waveforms. Such heterochromatic flicker reduces any noticeable flicker yet produces good results. If the colors are of equal luminance (but still different hues), the flicker should be imperceptible.
[0059] The overall dosage of light for the person 10 may be determined by a medical worker based on clinical trials and testing. Optimal dosage levels for different types of persons, such as patients, are still being studied, but a reasonable dosage is one-hour of the person 10 looking directly at the light source 14. Such a session may be performed at the same time every day. The person 10 may be periodically evaluated by a medical worker to correlate the gamma brain stimulation with the effects of Alzheimer's or other disorder. Cognitive testing may be done as well as testing to determine the presence of certain proteins and other chemicals in the person's body. Testing may include an EEG (electroencephalography). It is vital, for evaluation, to know exactly what dosage of light has been given to the person 10.
[0060] The Applicants have discovered that the effective dosage of neural entrainment light is highly influenced by combinations of gaze angle, eye distance from the light source, and pupil size, although compensation for any one of these factors helps achieve the target dosage. The actual dosage corresponds to a certain brain stimulation session duration given the particular gaze angles, eye distances, and pupil sizes during the session. Adjustments for gaze angle are the most significant for achieving the target light dosage.
[0061] The camera 18 (
[0062] A target light dosage is first established by the medical worker for the person 10 and this information is downloaded into the system 12, such as through the Internet. The target light dosage correlates to the session duration, given a known light optical output power and pulse frequency, with the person at a particular distance from the light source with an average pupil size. In one example, this target dosage assumes the person 10 is directly looking at the light source 14 at a distance of 50 cm with an average pupil size. The actual effective dosage, however, is reduced if the person 10 does not look directly at the light source 14, or is further than 50 cm away, or has a smaller than average pupil size.
[0063] As described with respect to
[0064] The detected distance from the light source will have a non-linear correlation to the actual effective dosage, since the effect of the light is non-linearly diminished as the person 10 moves from 50 cm to 100 cm from the light source. Similarly, the pupil size has a non-linear effect on the actual dosage.
[0065] Also, as shown in
[0066] An EEG is normally used as a test that detects abnormalities in brain waves or abnormalities in the electrical activity of the brain. During the procedure, electrodes consisting of small metal discs with thin wires are pasted onto the user's scalp or positioned close to the scalp such as by using a headpiece. The electrodes detect weak electrical emissions that result from the activity of the brain cells.
[0067] We instead detect the EEG signals from the brain to detect the coupling of the gamma and theta rhythms and then adjust the phase of the light stimulation pulses to maximize the coupling.
[0068] In
[0069]
[0070] In
[0071] Suitable gaze detection systems for customization are available from SR Research, Tobii AB, and other companies. A fully customized system can also be fabricated using a Raspberry Pi Camera Module v2 in conjunction with a Raspberry Pi 3 Model B+ single board computer. Much of the software is commercially available.
[0072] The raw digital data from the camera 18 is then processed by a processor running an algorithm in the eye tracking module 22. Such algorithms may consist of publically available software customized for the present invention. For the present invention, the software uses the resulting information about gaze angle, distance, and pupil size to dynamically control the dosage so that the person 10 ultimately receives the target dosage, in particular when the person is a patient.
[0073] The output of the eye tracking module 22 is then used to adjust the dosage that is controlled by the dosage controller 24. The dosage controller 24 initially receives a target dosage from the medical worker, which may correlate to a one hour session. This target session time is then automatically extended based on deviations from the ideal conditions of direct gaze, 50 cm distance, and average pupil size.
[0074]
[0075] In another embodiment, the current supplied to the light source 14 is sinusoidal, and the energizing current is a gamma frequency and the gamma frequency plus a theta frequency.
[0076] The required session time is displayed to the person 10 on a display screen 28, so the person 10 knows that the session time has been extended due to the person 10 gazing away or being further than 50 cm from the light source 14. The display screen 28 may use data generated by the local system or generated by a remote system communicating via the Internet.
[0077] A memory 30 stores the results of the session so the medical worker has accurate data regarding the dosage.
[0078] Communications hardware 32 may convey the data to the medical worker and update the system with upcoming session information.
[0079]
[0080] In
[0081] The eyes are also detected and processed by quantitative fixed thresholding algorithms (block 42). This process uses contrast thresholds (binarization) to determine objects, such as irises and pupils. Based on this data, the pupil angle is estimated (block 44). From this, the angle of gaze is computed trigonometrically and, after correcting for any off-set (block 46) of the integrated camera 18 lens relative to the light source, the resulting angle is passed to the data packaging block 40 before capturing the next frame. The dosage may be adjusted dynamically from frame to frame or may just be adjusted nearer the end of the session.
[0082] If no face is detected, a “user absence” signal is generated, and no power is applied to the light source.
[0083] The packaged data is applied to the dosage controller 24 of
[0084]
[0085] In step 50, the 40 Hz/47 Hz strobing light source is turned on to emit the stimulating light 52. The gaze detection system detects the person's distance, gaze angle, and pupil diameter (step 54) as the person's eye receives the light (step 56). The brain then undergoes neural entrainment (step 58) (i.e., the capacity of the brain to naturally synchronize its brainwave frequencies with the rhythm of periodic external stimuli).
[0086] The target duration (step 60), provided by the medical worker or other source, is correlated with an expected or target dosage of the light (step 62). The real-time detection (step 64) during the analysis of step 54 is then correlated to any expected loss of dosage (step 66) due to gaze angle, etc. A look-up table may be used to correlate the data with the loss of dosage.
[0087] The dose correction step 68 then subtracts the loss of dose from the “ideal conditions” dose to derive the actual effective dose being received by the person. The effective dose information (step 69) is then used to extend the session, as needed, to achieve the target dose.
[0088] The data obtained from the session and from testing the person, such as in particular a patient, may be used to further the understanding of the effects of the gamma brain stimulation on, for example, Alzheimer's disease or other neurological or psychiatric disorder (i.e. brain network dysfunctions).
[0089]
[0090] In step 72, the light source and gaze tracker are activated to start the session.
[0091] In step 74, the detected gaze angle, eye distance, and pupil diameter are correlated with a reduction of the effective dosage.
[0092] In step 76, the session time is extended, as required, to compensate for the detected gaze angle, eye distance, and pupil diameter. In another embodiment, the target dosage presumes some variation from ideal of the detected gaze angle, eye distance, and pupil diameter, and the system can add or subtract from the session time.
[0093] In parallel with detecting the effective dosage, the phase of the light stimulation is controlled to maximize theta-gamma coupling in the brain. The system for adjusting the phase was described with respect to
[0094] In step 80, the EEG signals are processed, and the phase of the light stimulation system is dynamically adjusted so that the two detected EEG signals have a high coupling, such as shown on the left side of
[0095] In step 82, the session data is stored in a memory for evaluating the efficacy of the treatment.
[0096] In step 84, a communications system conveys the data to a clinic or other medical worker. The communications system can also receive information, such as the target dose.
[0097] The system may be used for therapy or just to analyze the effects of the optical gamma/theta brain stimulation on a group of similar persons for collecting further data for study. Other strobing frequencies besides 40 Hz and 47 Hz, as previously mentioned, may prove valuable with further studies.
[0098] The invention is not limited to a gamma/theta brain stimulation rate of 20-140 Hz and 4-10 Hz. Other frequency light pulses emitted by the light source 14 may be beneficial for beta brain waves (beta brain stimulation rate of 13-38 Hz) and circadian functions. By generating light greater than a frequency that causes perceptible flicker, and also generating light at that frequency plus a lower frequency, the original frequency and the subtraction frequency are perceived internal to the brain without the detection of flicker.
[0099] In another embodiment, the system is only used for gamma wave stimulation.
[0100] In other embodiment, the optical system of
[0101] The phases of the gamma and theta waves may also be varied for testing the results of different phases.
Definitions
[0102] The term “gamma/theta brain stimulation” means a stimulus, such as a light source, that can change the neuronal gamma and theta activity in the brain.
[0103] The term “person” means a subject to be subjected to gamma/theta brain stimulation, such as a patient exhibiting symptoms of a brain disease such as Alzheimers, or such as a person who desires pre-emptive gamma/theta brain stimulation, or a test-person who is subjected to gamma/theta brain stimulation for instructive or test purposes.
[0104] The term “stimulation session” means a procedure over time where the person is exposed to a brain-stimulating device to receive a certain dosage of light. A single stimulation session is typically conducted within a day, but a customized session can be expanded and individualized to comprise multiple days, weeks, or months.
[0105] The term “stimulation duration” means a time period of a stimulation session, but is not limited to comprising the whole session duration, since the stimulation session time period can be broken up into multiple individual durations allowing for “interval” training, such as 15 minutes×4=60 minute session.
[0106] Strobing and flickering are used interchangeably in this application.
[0107] While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that changes and modifications may be made without departing from this invention in its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications that are within the true spirit and scope of this invention.